Samer Tannus — Endo Lab

other 2020

Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in vitro fertilization cycles of women with stage I-II endometriosis

F&S science ·doi:10.1016/j.xfss.2020.06.005

OBJECTIVE: To determine whether 2 months of pretreatment with 5 mg of letrozole daily plus leuprolide acetate at 3.75 mg monthly in women with laparoscopically confirmed American Society of Reproductive Medicine stage I-II endometriosis imp…

article 2019

Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure

Fertility and sterility ·doi:10.1016/j.fertnstert.2019.03.021

ObjectiveTo compare the influence of dual suppression with the use of GnRH agonist plus aromatase inhibitor compared with suppression with the use of GnRH agonist alone or no suppression at all in patients with idiopathic recurrent implanta…

article 2018

A comparison of pre-treatment with and without GnRH-agonist or letrozole in women with 2 failed embryo transfers undergoing a frozen cycle and no evidence of endometriosis

·doi:10.1016/j.fertnstert.2018.07.557

article 2018

A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF

Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2018.12.028

Research questionDoes the addition of an aromatase inhibitor improve IVF outcomes in women with endometriomas when pretreating them with gonadotrophin-releasing hormone agonists?DesignRetrospective two-centre cohort study involving 126 wome…

article 2009

RETRACTED ARTICLE: Endometrial Cancer Presenting as Acute Urinary Retention: a Case Report and Review of the Literature

·doi:10.1186/1757-1626-2-9388

Abstract Introduction Endometrial cancer is the most common gynecologic malignancy. Most women present with abnormal vaginal bleeding. Cervical stenosis can prevent early uterine bleeding leading to delayed diagnosis of the disease. Case pr…